Evidence map›Paper›PMID 41828067›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Development of microRNA-Based Glioblastoma Biomarkers Using Blood Plasma Specimens.

Sophia Giliberto, Kenny K Ablordeppey, Jacob Goldman, Melinda Yin, Rahul Chowdhury, Jacob Till, Kira Sheinerman, Sydney D Finkelstein, Samuil Umansky, Alidad Mireskandari and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sophia GilibertoPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kenny K AblordeppeyDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.ORCID 0000-0002-6645-4019
Jacob GoldmanDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.
Melinda YinPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0009-0001-1529-0544
Rahul ChowdhuryPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jacob TillPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Kira SheinermanDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.
Sydney D FinkelsteinDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.
Samuil UmanskyDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.
Alidad MireskandariDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.
Gyanendra KumarDiamiR Biosciences Laboratory, 2 Church Street South, Suite B05, New Haven, CT 06519, USA.ORCID 0000-0002-8282-9116
Erica L CarpenterPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Stephen J BagleyPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0002-7117-0539

Funding

Diamir (United States) N/AJames and Marlene Scully Innovation Fund N/ANational Center for Advancing Translational Sciences of the National Institutes of Health UL1TR001878Steven Elek, III GBM Research Fund N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerglioblastomaliquid biopsymicroRNA

Identifiers

PMID41828067
PMCPMC12985195

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.